References
- Bahn RS, Heufelder AE. Pathogenesis of Graves’ ophthalmopathy. N Engl J Med. 1993;329:1468–1475. doi:https://doi.org/10.1056/NEJM199311113292007.
- Garrity JA, Bahn RS. Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol. 2006;142(1):147–153. doi:https://doi.org/10.1016/j.ajo.2006.02.047.
- Kemp EG, Rootman J. Lipid deposition within the extra-ocular muscles of a patient with dysthyroid ophthalmopathy. Orbit. 1989;8(1):45–48. doi:https://doi.org/10.3109/01676838909056371.
- Özgen A, Alp MN, Ariyürek M, Tütüncü NB, Can I, Quantitative GI. CT of the orbit in Graves’ disease. Br J Radiol. 1999;72(860):757–762. doi:https://doi.org/10.1259/bjr.72.860.10624341.
- Regensburg NI, Wiersinga WM, Berendschot TT, Peerooz S, Mourits MP. Densities of orbital fat and extraocular muscles in Graves orbitopathy patients and controls. Ophthalmic Plast Reconstr Surg. 2011;27(4):236–240. doi:https://doi.org/10.1097/IOP.0b013e31820365d5.
- Uhlenbrock D. Computed tomography in Graves’ ophthalmopathy-evaluation regarding the muscle size and density units. Neurosurg Rev. 1988;11(1):45–51. doi:https://doi.org/10.1007/BF01795694.
- Parmar H, Ibrahim M. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy. Neuroimag Clin N Am. 2008;18(3):527–536. doi:https://doi.org/10.1016/j.nic.2008.03.003.
- Potgieser PW, de Win MMML, Wiersinga WM, Mourits MP. Natural course of mild Graves orbitopathy: increase of orbital fat but decrease of muscle volume with increased muscle fatty degeneration during a 4-year follow-up. Ophthalmic Plast Reconstr Surg. 2019;35(5):456–460. doi:https://doi.org/10.1097/IOP.0000000000001319.
- Papageorgiou KI, Hwang CJ, Chang SH, Jarullazada I, Garneau HC, Ang MJ, et al. Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy. Arch Ophthalmol. 2012;130(3):319–328. doi:https://doi.org/10.1001/archopthalmol.2011.1271.
- Papageorgiou KI, Mancini R, Garneau HC, Chang SH, Jarullazada I, King A, et al. A three-dimensional construct of the aging eyebrow: the illusion of volume loss. Aesthet Surg J. 2012;32(1):46–57. doi:https://doi.org/10.1177/1090820X11430829.
- Rootman J. Thyroid orbitopathy. In: Diseases of the Orbit: A Multidisciplinary Approach. 2nd ed. Philadelphia: LWW; 2003:182–186.
- Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves’ disease on orbital computed tomography. J Comput Assist Tomogr. 1979;3(6):815–819. doi:https://doi.org/10.1097/00004728-197903060-00019.
- Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, et al. Graves orbitopathy: correlation of CT and clinical findings. Radiology. 1990;177:675–682. doi:https://doi.org/10.1148/radiology.177.3.2243967.
- Wilkes TDE, Adams DF. Involutional (senile) ptosis. Geriatr Ophthalmol. 1986;2:14–22.
- Brioche T, Pagano AF, Py G, Chopard A. Muscle wasting and aging: experimental models, fatty infiltrations, and prevention. Mol Aspects Med. 2016;50:56–87. doi:https://doi.org/10.1016/j.mam.2016.04.006.
- Lo C, Ugradar S, Rootman D. Orbital imaging in thyroid-related orbitopathy. J Aapos. 2018;22(4):256.e1-9. doi:https://doi.org/10.1016/j.jaapos.2018.06.002.
- Kahaly GJ. Imaging in thyroid-associated orbitopathy. Eur J Endocrinol. 2001;145:107–118. doi:https://doi.org/10.1530/eje.0.1450107.
- Das T, Roos JCP, Patterson AJ, Graves MJ, Murthy R. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Eye (Lond). 2019;33(2):235–243. doi:https://doi.org/10.1038/s41433-018-0304-z.